tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Value
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Smart Value
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

Eupraxia Pharmaceuticals Reports Strong Q4 2024 Results and Operational Progress
Company AnnouncementsEupraxia Pharmaceuticals Reports Strong Q4 2024 Results and Operational Progress
2h ago
EPRX
Eupraxia Pharmaceuticals reports FY24 EPS (76c), consensus (63c)
PremiumThe Fly
Eupraxia Pharmaceuticals reports FY24 EPS (76c), consensus (63c)
2h ago
EPRX
Eupraxia Pharmaceuticals management to meet virtually with Craig-Hallum
PremiumThe Fly
Eupraxia Pharmaceuticals management to meet virtually with Craig-Hallum
16d ago
EPRX
Eupraxia Pharmaceuticals Reports Promising Trial Results for Eosinophilic Esophagitis Treatment
PremiumCompany Announcements
Eupraxia Pharmaceuticals Reports Promising Trial Results for Eosinophilic Esophagitis Treatment
23d ago
EPRX
Eupraxia Pharmaceuticals’ EP-104GI shows efficacy in esophagitis trial
PremiumThe Fly
Eupraxia Pharmaceuticals’ EP-104GI shows efficacy in esophagitis trial
23d ago
EPRX
Craig-Hallum starts Eupraxia at Buy, sees ‘significant upside’ potential
PremiumThe FlyCraig-Hallum starts Eupraxia at Buy, sees ‘significant upside’ potential
27d ago
EPRX
Eupraxia Pharmaceuticals initiated with a Buy at Craig-Hallum
Premium
The Fly
Eupraxia Pharmaceuticals initiated with a Buy at Craig-Hallum
27d ago
EPRX
Eupraxia Pharmaceuticals Announces CFO Succession Amid Strategic Advancements
Premium
Company Announcements
Eupraxia Pharmaceuticals Announces CFO Succession Amid Strategic Advancements
1M ago
6K
EPRX
Eupraxia Pharmaceuticals announces CFO succession
PremiumThe Fly
Eupraxia Pharmaceuticals announces CFO succession
1M ago
EPRX
Eupraxia Pharmaceuticals Unveils Promising Drug Delivery Data
PremiumCompany Announcements
Eupraxia Pharmaceuticals Unveils Promising Drug Delivery Data
4M ago
EPRX
Eupraxia presents new PK data from its Phase 2a Eosinophilic Esophagitis program
PremiumThe Fly
Eupraxia presents new PK data from its Phase 2a Eosinophilic Esophagitis program
4M ago
EPRX
Eupraxia Pharmaceuticals Showcases Innovation at ACR 2024
PremiumCompany Announcements
Eupraxia Pharmaceuticals Showcases Innovation at ACR 2024
4M ago
EPRX
Eupraxia Pharmaceuticals initiated with a Buy at Rodman & Renshaw
PremiumThe FlyEupraxia Pharmaceuticals initiated with a Buy at Rodman & Renshaw
4M ago
EPRX
Eupraxia Pharmaceuticals initiated with a Buy at Rodman & Renshaw
Premium
The Fly
Eupraxia Pharmaceuticals initiated with a Buy at Rodman & Renshaw
4M ago
EPRX
Eupraxia Pharmaceuticals Hosts Webinar on Digestive Disorders
Premium
Company Announcements
Eupraxia Pharmaceuticals Hosts Webinar on Digestive Disorders
4M ago
EPRX
Eupraxia Pharmaceuticals Reports Promising Trial Results
PremiumCompany Announcements
Eupraxia Pharmaceuticals Reports Promising Trial Results
4M ago
EPRX
Eupraxia reports data from RESOLVE Phase 1b/2a trial
PremiumThe Fly
Eupraxia reports data from RESOLVE Phase 1b/2a trial
4M ago
EPRX
Eupraxia Pharmaceuticals Reports Q3 Progress and Funding
PremiumCompany Announcements
Eupraxia Pharmaceuticals Reports Q3 Progress and Funding
4M ago
EPRX
EPRX Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
EPRX Upcoming Earnings Report: What to Expect?
5M ago
EPRX
Eupraxia Pharmaceuticals Secures C$44.5 Million Investment
PremiumCompany AnnouncementsEupraxia Pharmaceuticals Secures C$44.5 Million Investment
5M ago
EPRX
Eupraxia Pharmaceuticals Showcases Innovations in Drug Delivery
Premium
Company Announcements
Eupraxia Pharmaceuticals Showcases Innovations in Drug Delivery
5M ago
6K
EPRX
Eupraxia’s EP-104IAR Gains Attention in Rheumatology
Premium
Company Announcements
Eupraxia’s EP-104IAR Gains Attention in Rheumatology
5M ago
EPRX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >